BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 18534709)

  • 1. Three-day tetrahydrobiopterin therapy increases in vivo hepatic NOS activity and reduces portal pressure in CCl4 cirrhotic rats.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; García-Calderó H; Fernández M; Bosch J; Garcia-Pagán JC
    J Hepatol; 2008 Aug; 49(2):192-7. PubMed ID: 18534709
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Superoxide dismutase gene transfer reduces portal pressure in CCl4 cirrhotic rats with portal hypertension.
    Laviña B; Gracia-Sancho J; Rodríguez-Vilarrupla A; Chu Y; Heistad DD; Bosch J; García-Pagán JC
    Gut; 2009 Jan; 58(1):118-25. PubMed ID: 18829979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of vascular nitric oxide production and systemic hemodynamics in cirrhosis versus prehepatic portal hypertension in rats.
    Niederberger M; Ginés P; Martin PY; Tsai P; Morris K; McMurtry I; Schrier RW
    Hepatology; 1996 Oct; 24(4):947-51. PubMed ID: 8855203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The eNOS cofactor tetrahydrobiopterin improves endothelial dysfunction in livers of rats with CCl4 cirrhosis.
    Matei V; Rodríguez-Vilarrupla A; Deulofeu R; Colomer D; Fernández M; Bosch J; Garcia-Pagán JC
    Hepatology; 2006 Jul; 44(1):44-52. PubMed ID: 16799985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
    Sansoè G; Aragno M; Mastrocola R; Restivo F; Mengozzi G; Smedile A; Rosina F; Danni O; Parola M; Rizzetto M
    J Hepatol; 2005 Nov; 43(5):791-8. PubMed ID: 16085334
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroflurbiprofen, a nitric oxide-releasing cyclooxygenase inhibitor, improves cirrhotic portal hypertension in rats.
    Laleman W; Van Landeghem L; Van der Elst I; Zeegers M; Fevery J; Nevens F
    Gastroenterology; 2007 Feb; 132(2):709-19. PubMed ID: 17258737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simvastatin treatment improves liver sinusoidal endothelial dysfunction in CCl4 cirrhotic rats.
    Abraldes JG; Rodríguez-Vilarrupla A; Graupera M; Zafra C; García-Calderó H; García-Pagán JC; Bosch J
    J Hepatol; 2007 Jun; 46(6):1040-6. PubMed ID: 17335931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Salviae miltiorrhizae ameliorates cirrhosis and portal hypertension by inhibiting nitric oxide in cirrhotic rats.
    Wang H; Chen XP; Qiu FZ
    Hepatobiliary Pancreat Dis Int; 2003 Aug; 2(3):391-6. PubMed ID: 14599946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant human manganese superoxide dismutase reduces liver fibrosis and portal pressure in CCl4-cirrhotic rats.
    Guillaume M; Rodriguez-Vilarrupla A; Gracia-Sancho J; Rosado E; Mancini A; Bosch J; Garcia-Pagán JC
    J Hepatol; 2013 Feb; 58(2):240-6. PubMed ID: 22989570
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tempol administration, a superoxide dismutase mimetic, reduces hepatic vascular resistance and portal pressure in cirrhotic rats.
    García-Calderó H; Rodríguez-Vilarrupla A; Gracia-Sancho J; Diví M; Laviña B; Bosch J; García-Pagán JC
    J Hepatol; 2011 Apr; 54(4):660-5. PubMed ID: 21159403
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amelioration of portal hypertension and the hyperdynamic circulatory syndrome in cirrhotic rats by neuropeptide Y via pronounced splanchnic vasoaction.
    Moleda L; Trebicka J; Dietrich P; Gäbele E; Hellerbrand C; Straub RH; Sauerbruch T; Schoelmerich J; Wiest R
    Gut; 2011 Aug; 60(8):1122-32. PubMed ID: 21317421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Terutroban, a TP-receptor antagonist, reduces portal pressure in cirrhotic rats.
    Rosado E; Rodríguez-Vilarrupla A; Gracia-Sancho J; Tripathi D; García-Calderó H; Bosch J; García-Pagán JC
    Hepatology; 2013 Oct; 58(4):1424-35. PubMed ID: 23703868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence against a role for NADPH oxidase modulating hepatic vascular tone in cirrhosis.
    Gracia-Sancho J; Laviña B; Rodríguez-Vilarrupla A; Brandes RP; Fernández M; Bosch J; García-Pagán JC
    Gastroenterology; 2007 Sep; 133(3):959-66. PubMed ID: 17854599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of bile duct-ligated rats with the nitric oxide synthase transcription enhancer AVE 9488 ameliorates portal hypertension.
    Biecker E; Trebicka J; Kang A; Hennenberg M; Sauerbruch T; Heller J
    Liver Int; 2008 Mar; 28(3):331-8. PubMed ID: 18290775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Dexamethasone, an inhibitor of the expression of inducible nitric oxide synthase, does not modify the hyperdynamic state in cirrhotic rats].
    Albornoz L; Bandi JC; de las Heras M; Mastai R
    Medicina (B Aires); 2000; 60(4):477-81. PubMed ID: 11188955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resveratrol improves intrahepatic endothelial dysfunction and reduces hepatic fibrosis and portal pressure in cirrhotic rats.
    Di Pascoli M; Diví M; Rodríguez-Vilarrupla A; Rosado E; Gracia-Sancho J; Vilaseca M; Bosch J; García-Pagán JC
    J Hepatol; 2013 May; 58(5):904-10. PubMed ID: 23262250
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NO as an indicator of portal hemodynamics and the role of iNOS in increased NO production in CCl4-induced liver cirrhosis.
    Mizumoto M; Arii S; Furutani M; Nakamura T; Ishigami S; Monden K; Ishiguro S; Fujita S; Imamura M
    J Surg Res; 1997 Jul; 70(2):124-33. PubMed ID: 9245560
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Liposome-mediated gene transfer of endothelial nitric oxide synthase to cirrhotic rat liver decreases intrahepatic vascular resistance.
    Zhang ZQ; Qiu JF; Luo M; Sun YW; Zhao G; Chen W; Liu H; Wu ZY
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 2):e487-93. PubMed ID: 18070013
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Administration of a low dose of sildenafil for 1 week decreases intrahepatic resistance in rats with biliary cirrhosis: the role of NO bioavailability.
    Lee KC; Yang YY; Huang YT; Lee FY; Hou MC; Lin HC; Lee SD
    Clin Sci (Lond); 2010 Apr; 119(1):45-55. PubMed ID: 20132096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of nitric oxide synthase and cyclooxygenase blockade on expression of cyclooxygenase and hemodynamics in rats with portal hypertension.
    Cao H; Xu J; Liu H; Meng FB; Qiu JF; Wu ZY
    Hepatobiliary Pancreat Dis Int; 2006 Nov; 5(4):564-9. PubMed ID: 17085343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.